The overall decrease of PCs may be associated with reduction of high-density lipoprotein (HDL) cholesterol and ApoA1 in the ovarian cancer patients,17,18 as PCs are known to be abundant especially in the HDL particles.19 However, this phenomenon cannot be used to explain the increase of lipid species in ovarian cancer patients. Here, APOA1 is linked to ovarian cancer.